Piramal Pharma Stock Performance Analyzed
Piramal Pharma’s stock price is currently at Rs 157.07, representing a slight decrease of 0.47% for the day, as of 13:19 IST on the NSE. This comes after a challenging year for the company, with the stock falling by 35.18% overall. This underperformance contrasts sharply with the broader market and sector trends.
Key Points
- Piramal Pharma stock down 0.47% today, at Rs 157.07.
- Stock fell 35.18% in the past year, lagging NIFTY and Pharma.
- Nifty Pharma index down 0.31% today, influenced by Piramal Pharma.
- One-month stock decline: 11.61%, one-month Pharma index decline: 5.58%.
- High trading volume today (23.5 lakh shares), lower than recent average.
- PE ratio currently 29.71 based on September 25th earnings data.
The NIFTY index is down approximately 0.07% today, trading at 25214.4, while the Sensex is down 0.03% at 82152.2. These broader market movements highlight a potentially concerning trend for Piramal Pharma. The company’s recent performance is noticeably weaker than the rest of the market.
Over the last month, Piramal Pharma has seen a decline of around 11.61%, while the Nifty Pharma index, which includes Piramal Pharma, has decreased by approximately 5.58% during the same period. The index is currently at 21714.3, with a daily decrease of 0.31%.
Trading volume today was 23.5 lakh shares, which is lower than the average of 30.73 lakh shares seen over the past month. This could indicate reduced investor interest or strategic trading. The January futures contract for the stock is currently down 0.88% at Rs 156.7.
The company’s Price-to-Earnings (PE) ratio stands at 29.71, calculated using earnings data ending September 25th. This is a key metric investors use to assess the stock’s valuation relative to its profits.
Investors should carefully monitor Piramal Pharma’s performance against its sector and broader market benchmarks for potential investment opportunities.
